Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy

Objective: Natalizumab is an effective treatment for patients with multiple sclerosis (MS) that is associated with a risk of progressive multifocal leukoencephalopathy (PML). Recommendations were published in 2006 to improve early diagnosis of PML using magnetic resonance imaging (MRI). However, due...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Annals of neurology Ročník 72; číslo 5; s. 779 - 787
Hlavní autoři:	Yousry, Tarek A., Pelletier, Daniel, Cadavid, Diego, Gass, Achim, Richert, Nancy D., Radue, Ernst-Wilhelm, Filippi, Massimo
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.11.2012 Wiley-Liss Wiley Subscription Services, Inc
Témata:	Adult Antibodies, Monoclonal, Humanized - adverse effects Biological and medical sciences Brain - pathology Female Follow-Up Studies Human immunodeficiency virus Humans Image Processing, Computer-Assisted Investigative techniques, diagnostic techniques (general aspects) Leukoencephalopathy, Progressive Multifocal - chemically induced Leukoencephalopathy, Progressive Multifocal - pathology Magnetic Resonance Imaging Male Medical sciences Middle Aged Multiple sclerosis Multiple Sclerosis - drug therapy Natalizumab Nervous system Neurology NMR Nuclear magnetic resonance Product Surveillance, Postmarketing Radiodiagnosis. Nmr imagery. Nmr spectrometry Retrospective Studies Time Factors Infection Virus Nervous system diseases Natalizumab Viral disease Central nervous system disease Nuclear magnetic resonance imaging Inflammatory disease Cerebral disorder Progressive multifocal leukoencephalopathy Slow virus
ISSN:	0364-5134, 1531-8249, 1531-8249
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!